Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment
Open Access
- 24 August 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 61 (suppl 2), S69-S78
- https://doi.org/10.1093/cid/civ528
Abstract
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians. Although uncomplicated SSTIs are managed successfully on an outpatient basis, more serious infections extending to the subcutaneous tissue, fascia, or muscle require complex management. Early diagnosis, selection of appropriate antimicrobials, and timely surgical intervention are key to successful treatment. Surgical-site infections, an important category of SSTI, occur in approximately half a million patients in North America annually. SSTIs are also a potential source for life-threatening bacteremia and metastatic abscesses. Gram-positive organisms, such as Staphylococcus aureus and Streptococcus pyogenes, are the dominant organisms isolated early in the infectious process, whereas gram-negative organisms are found in chronic wounds. Methicillin-resistant S. aureus (MRSA) is a potential bloodstream invader that requires aggressive antimicrobial treatment and surgery. Recent concerns regarding vancomycin activity include heteroresistance in MRSA and increase in the minimum inhibitory concentrations (>1 or 2 µg/mL); however, alternative agents, such as telavancin, daptomycin, linezolid, ceftaroline, dalbavancin, oritavancin, and tedizolid, are now available for the treatment of severe MRSA infections. Here, we present a review of the epidemiology, etiology, and available treatment options for the management of SSTIs.Keywords
This publication has 73 references indexed in Scilit:
- Impact of Evolving Epidemiology on Treatments for Complicated Skin and Skin Structure Infections: The Surgical PerspectiveJournal of the American College of Surgeons, 2015
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2014
- Incidence and cost of hospitalizations associated with Staphylococcus aureusskin and soft tissue infections in the United States from 2001 through 2009BMC Infectious Diseases, 2014
- Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based studyBMC Infectious Diseases, 2013
- Skin and soft-tissue infections: Classifying and treating a spectrumCleveland Clinic Journal of Medicine, 2012
- Skin and Soft Tissue Infections: The New Surgical Infection Society GuidelinesSurgical Infections, 2011
- Trends in US Hospital Admissions for Skin and Soft Tissue InfectionsEmerging Infectious Diseases, 2009
- Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site Of CareCanadian Journal of Infectious Diseases and Medical Microbiology, 2008
- Rapidly progressive soft tissue infectionsThe Lancet Infectious Diseases, 2005
- Managing skin and soft tissue infections: expert panel recommendations on key decision pointsJournal of Antimicrobial Chemotherapy, 2003